Intellipharmaceutics "SPECULATIVE BUY"
Analysts at Mackie initiated coverage of Intellipharmaceutics with a "SPECULATIVE BUY" rating on Wednesday and a 12-month target price of $11.00
Get a handle on your personal finance needs with the basic savings calculator.
Volatile stock markets? Figure out your gains and losses with this tool.
How much will you need for your retirement? Check out this RRSP calculator.